RxDoctor Payments Data

Melissa Werner

Psychiatric/Mental Health · Bowling Green, KYNPI 1952060691

Payments from drug & device makers

$5,794in general payments, 2019–2025

Across 269 payments — averaging $21.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Ancora Heart, Inc.$1K
  • AbbVie$678
  • Axsome Therapeutics, Inc.$566
  • Otsuka America Pharmaceutical, Inc.$462
  • Neurocrine Biosciences, Inc.$420
  • Alkermes, Inc.$412
  • plus $2K from 12 others

What the payments were for

  • Travel & lodging$67212%
  • Food & beverage$5,12288%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,794 in reported general payments places this provider in the 90th percentile of 946 psychiatric/mental health providers in Kentucky.

See all psychiatric/mental health providers in Kentucky

Medicare billing

Part B allowed, 2024
$6,242
Medicare patients
21
Services billed
79

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrintellixVortioxetine Hydrobromide15$7,930
Olanzapine12$878
Trazodone Hcl20$457
AmantadineAmantadine Hcl13$286
Venlafaxine Hcl ErVenlafaxine Hcl17$256
Sertraline Hcl12$194
Propranolol Hcl12$135
Mirtazapine13$134
Quetiapine Fumarate16$123
Risperidone14$121
Alprazolam18$114
Buspirone Hcl17$111
Clonazepam27$81
Lorazepam13$40
Zolpidem Tartrate14$31

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$81$7,93015 claims
Almatica Pharma LLCSertraline Hcl$58$19412 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 946 psychiatric/mental health providers in Kentucky.

Other psychiatric/mental health in Bowling Green

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →